Literature DB >> 15488753

Antagonism of Myc functions by Arf.

John L Cleveland1, Charles J Sherr.   

Abstract

The Arf-Mdm2-p53 tumor suppressor pathway is activated by sustained hyperproliferative signals emanating from oncoproteins such as Myc. A recent study reveals a novel level of feedback control, whereby induced p19(Arf) binds to Myc and blocks cell proliferation by selectively impairing its transactivation functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488753     DOI: 10.1016/j.ccr.2004.09.020

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  19 in total

1.  Mouse models of cancer as biological filters for complex genomic data.

Authors:  Elisa Oricchio; Andrew L Wolfe; Jonathan H Schatz; Konstantinos J Mavrakis; Hans-Guido Wendel
Journal:  Dis Model Mech       Date:  2010-09-27       Impact factor: 5.758

Review 2.  What has senescence got to do with cancer?

Authors:  Goberdhan P Dimri
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

3.  Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis.

Authors:  Da-Qiang Li; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Jun-Xiang Zhang; Lei Wang; Yanping Zhang; Ignacio Moreno de Alborán; M Radhakrishna Pillai; Jeyanthy Eswaran; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

4.  Borealin is repressed in response to p53/Rb signaling.

Authors:  Dipali A Date; Cara J Jacob; Mike E Bekier; Andrew C Stiff; Mark W Jackson; William R Taylor
Journal:  Cell Biol Int       Date:  2007-07-15       Impact factor: 3.612

5.  Role of the translocation partner in protection against AID-dependent chromosomal translocations.

Authors:  Mila Jankovic; Davide F Robbiani; Yair Dorsett; Thomas Eisenreich; Yang Xu; Alexander Tarakhovsky; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  Linking the p53 tumour suppressor pathway to somatic cell reprogramming.

Authors:  Teruhisa Kawamura; Jotaro Suzuki; Yunyuan V Wang; Sergio Menendez; Laura Batlle Morera; Angel Raya; Geoffrey M Wahl; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

7.  Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.

Authors:  Zhenbang Chen; Arkaitz Carracedo; Hui-Kuan Lin; Jason A Koutcher; Nille Behrendt; Ainara Egia; Andrea Alimonti; Brett S Carver; William Gerald; Julie Teruya-Feldstein; Massimo Loda; Pier Paolo Pandolfi
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

8.  Ribosomal protein S14 negatively regulates c-Myc activity.

Authors:  Xiang Zhou; Qian Hao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

9.  Antimalarial therapy prevents Myc-induced lymphoma.

Authors:  Chi V Dang
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

10.  Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway.

Authors:  Motoshi Nagao; Kenneth Campbell; Kevin Burns; Chia-Yi Kuan; Andreas Trumpp; Masato Nakafuku
Journal:  J Cell Biol       Date:  2008-12-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.